Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)
Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to learn about the efficacy of a medication called
varenicline (Chantix) in treating ADHD in adults and in reducing cigarette smoking in adults
with ADHD. The investigators hypothesize that ADHD symptomatology in adults with ADHD will be
improved with varenicline treatment. The investigators also hypothesize that varenicline
treatment will result in significant reductions in cigarette smoking. Another objective of
this study is to more fully evaluate the response and tolerability to varenicline in this
group of cigarette smoking adults with ADHD.